SmithRx CSO on high drug prices impacting New Jersey: PBM ‘pressure is what leads to rising drug costs’
Alan Pannier, chief strategy officer at SmithRx, said on the Jim Stroud Podcast that opaque pricing and misaligned incentives by pharmacy benefit managers (PBMs) drive higher pharmacy costs and create burdens for employers and patients












